UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Transcriptional coactivation of c-Jun by the KSHV-encoded LANA

Blood, 2004-01, Vol.103 (1), p.222-228

2004

Volltextzugriff (PDF)

The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element

Blood, 2002-01, Vol.99 (2), p.649-654

2002

Volltextzugriff (PDF)

Rta of the human herpesvirus 8/Kaposi sarcoma–associated herpesvirus up-regulates human interleukin-6 gene expression

Blood, 2002-09, Vol.100 (5), p.1919-1921

2002

Volltextzugriff (PDF)

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma

Blood, 2000-09, Vol.96 (6), p.2304-2306

2000

Volltextzugriff (PDF)

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma

Blood, 1997-12, Vol.90 (11), p.4278-4282

1997

Volltextzugriff (PDF)

VH gene usage in multiple myeloma : Complete absence of the VH4.21 (V4-34) gene

Blood, 1996-04, Vol.87 (7), p.2846-2852

1996

Volltextzugriff (PDF)

Localization of Kaposi's Sarcoma–Associated Herpesvirus in Bone Marrow Biopsy Samples From Patients With Multiple Myeloma

Blood, 1997-12, Vol.90 (11), p.4278-4282

1997

Volltextzugriff (PDF)

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Blood, 2009-06, Vol.113 (24), p.6206-6214

2009

Volltextzugriff (PDF)

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Blood, 2021-02, Vol.137 (5), p.624-636

2021

Volltextzugriff (PDF)

Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells

Blood, 2017-05, Vol.129 (21), p.2939-2949

2017

Volltextzugriff (PDF)

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells

Blood, 2009-08, Vol.114 (7), p.1340-1343

2009

Volltextzugriff (PDF)

Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells

Blood, 2023-04, Vol.141 (14), p.1718-1723

2023

Volltextzugriff (PDF)

Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition

Blood, 2016-11, Vol.128 (20), p.2457-2461

2016

Volltextzugriff (PDF)

Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice

Blood, 2018-06, Vol.131 (23), p.2594-2596

2018

Volltextzugriff (PDF)

Modeling Flotetuzumab-Associated CRS in AML Using inVitro and inVivo Preclinical Models

Blood, 2022-11, Vol.140, p.8795-8796

2022

Volltextzugriff (PDF)

Modeling Flotetuzumab-Associated CRS in AML Using in Vitro and in Vivo Preclinical Models

Blood, 2022-11, Vol.140 (Supplement 1), p.8795-8796

2022

Volltextzugriff (PDF)

Conditioning for Hematopoietic Stem Cell Transplantation Using Antibody-Drug Conjugate Targeting CD45 Permits Engraftment across Immunologic Barriers

Blood, 2018-11, Vol.132 (Supplement 1), p.2035-2035

2018

Volltextzugriff (PDF)

Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.16-18

2020

Volltextzugriff (PDF)

Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab

Blood, 2020-11, Vol.136 (Supplement 1), p.19-21

2020

Volltextzugriff (PDF)

Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.26-28

2020

Volltextzugriff (PDF)

Myeloma Cell Associated Therapeutic Protein Discovery Using Single Cell RNA-Seq Data

Blood, 2020-11, Vol.136 (Supplement 1), p.4-5

2020

Volltextzugriff (PDF)

Ixazomib, an Oral Proteasome Inhibitor, Induces Rapid Mobilization of Hematopoietic Stem Cells in Mice

Blood, 2015-12, Vol.126 (23), p.513-513

2015

Volltextzugriff (PDF)

Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients

Blood, 2019-11, Vol.134 (Supplement_1), p.733-733

2019

Volltextzugriff (PDF)

Expansion and Maintenance of Hematopoietic Stem and Progenitor Cells in Course of Long-Term Inhibition of CXCR4/CXCL12 Signaling

Blood, 2016-12, Vol.128 (22), p.2648-2648

2016

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(5)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Transcriptional coactivation of c-Jun by the KSHV-encoded LANA

The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element

Rta of the human herpesvirus 8/Kaposi sarcoma–associated herpesvirus up-regulates human interleukin-6 gene expression

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma

VH gene usage in multiple myeloma : Complete absence of the VH4.21 (V4-34) gene

Localization of Kaposi's Sarcoma–Associated Herpesvirus in Bone Marrow Biopsy Samples From Patients With Multiple Myeloma

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells

Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells

Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition

Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice

Modeling Flotetuzumab-Associated CRS in AML Using inVitro and inVivo Preclinical Models

Modeling Flotetuzumab-Associated CRS in AML Using in Vitro and in Vivo Preclinical Models

Conditioning for Hematopoietic Stem Cell Transplantation Using Antibody-Drug Conjugate Targeting CD45 Permits Engraftment across Immunologic Barriers

Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia

Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab

TP53 Abnormalities Correlate with Immune Infiltration and Associate with Response to Flotetuzumab Immunotherapy in Acute Myeloid Leukemia

Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia

Myeloma Cell Associated Therapeutic Protein Discovery Using Single Cell RNA-Seq Data

Ixazomib, an Oral Proteasome Inhibitor, Induces Rapid Mobilization of Hematopoietic Stem Cells in Mice

Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients

Expansion and Maintenance of Hematopoietic Stem and Progenitor Cells in Course of Long-Term Inhibition of CXCR4/CXCL12 Signaling

Aktive Filter

Suchergebnisse filtern